Laser acupuncture for fatigue in adults on hemodialysis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, sham-controlled pilot study compares laser acupuncture to a sham procedure in adults undergoing hemodialysis. Fifty participants will be assigned 1:1 to receive treatment at specific acupuncture points during dialysis sessions for four weeks. Each session lasts 15–30 minutes, three times per week, and outcomes include fatigue severity, daily functioning, sleep, appetite, skin itching, microcirculation, and heart rate variability. The study aims to determine whether laser acupuncture can provide benefit beyond a placebo and explore potential mechanisms related to circulation and autonomic balance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with End-Stage Renal Disease (ESRD) who require regular maintenance hemodialysis.
* Must undergo hemodialysis treatment at least 3 times per week.
* Aged 18 years or older.
* Willing and able to provide informed consent to participate in the study.

Exclusion Criteria:

* Presence of acute infectious symptoms.
* Unstable vital signs.
* Diagnosis of malignant tumors.
* Pregnancy.
* Presence of open wounds at the sites designated for laser intervention.
* Patients with implanted cardiac pacemakers or other cardiac devices.

Where it's running

• Taipei City Hospital, Renai Branch
  Taipei, Taiwan Recruiting

Study contacts

• Study coordinator: Ming Jen Wang, MD
• Email: wanters0800@gmail.com
• Phone: +886-930-766-631

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AP301, an iron-based phosphate binder, for people on dialysis with high blood phosphate

  This study will test whether the iron-based drug AP301 can lower high blood phosphate in people with end-stage kidney disease who are on maintenance dialysis.

  Recruiting at 41 sites Phase 3 Alebund Pharmaceuticals · Granada Hills, California and 41 other locations · NCT06933472

• Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy

  This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.

  Recruiting at 12 sites Istituto Giannina Gaslini · Ancona and 11 other locations · NCT07918066

• Remote Ischaemic Conditioning for Fatigue After Stroke 2

  Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.

  Recruiting Phase 2 Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT07914647

• 3D Ultrasound Support for Hemodialysis Cannulation

  This study tests whether the EchoMap device can help safely cannulate an arm fistula during hemodialysis for adults.

  Recruiting at 3 sites Sonavex, Inc. · Hartford, Connecticut and 2 other locations · NCT07891741

• Micro-choice-based approach to fatigue management

  A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT07726082

• HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults

  This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.

  Recruiting at 29 sites Phase 3 Harmony Biosciences Management, Inc. · Birmingham, Alabama and 52 other locations · NCT07675135

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.